Clinical Trials Logo
  1. Home
  2. Other
  3. NCT04512846

Comparison of Efficacy in SBRT of Large HCC With or Without TACE

Stereotactic Body Radiation Therapy Clinical Trial

Official title:
Comparison of Efficacy in Stereotactic Body Radiation Therapy (SBRT) of Large Hepatocellular Carcinoma (5-10 cm) With or Without Transcatheter Arterial Chemoembolization (TACE)

Clinical Trial Summary

The study aims to compare efficacy and adverse reactions of large hepatocellular carcinoma participants (5-10cm) who receive stereotactic body radiation therapy with or without transcatheter arterial chemoembolization.The investigators will optimize the combined treatment schedule of SBRT for hepatocellular carcinoma participants by comparing overall survival rates, progression-free survival rates and local control and adverse reaction occurrence rates in the two groups.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

  • Large HCC Patients
  • Stereotactic Body Radiation Therapy
  • Transcatheter Arterial Chemoembolization
Clinical Trial Details
NCT number NCT04512846
Study type Observational
Source Beijing 302 Hospital
Contact Jing Sun
Phone +8613718681094
Email 519299998@qq.com
Status Recruiting
Phase
Start date August 1, 2020
Completion date August 30, 2026
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04161287 - Comparison of Efficacy in SBRT of HCC ≤5 cm With or Without TACE
Suspended NCT04020276 - OAR-Based, Dose Escalated SBRT With Real Time Adaptive MRI Guidance for Liver Metastases Phase 1
Recruiting NCT04940936 - Shared Decision Making on Radiation Dose for Lung Malignancies N/A
Recruiting NCT05189054 - Safety and Efficacy of SBRT in the Reirradiation for Ultra-central Thoracic Malignant Tumors
Not yet recruiting NCT05411809 - The ctDNA for Evaluating Whether to Use Adjuvant Therapy After SBRT in Patients With Early Lung Cancer N/A
Not yet recruiting NCT04351282 - SBRT for Oligo-metastatic Lesions After Systemic Treatment of Primary Metastatic Nasopharyngeal Carcinoma N/A
Recruiting NCT03253536 - Prospective Observational Trial to Evaluate Quality of Life After Stereotactic Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma N/A
Withdrawn NCT03431415 - Surgery Versus Stereotactic Body Radiation Therapy for Stage up to IA2 (T1a or T1b) Non-small Cell Lung Cancer N/A
Recruiting NCT05209243 - START-MET HS Prostate Cancer. : SbrT & Androgen Receptor Therapy METastatic HSPC N/A
Recruiting NCT02545751 - SBRT Combined With Thymalfasin for Metastatic Esophageal Cancer Phase 2
Completed NCT04912128 - Stereotactic Radiosurgery Combination With Anlotinib for Limited Brain Metastases in NSCLC
Completed NCT03340974 - Pilot Dose Escalation Trial of Stereotactic Body Radiation Therapy (SBRT) in Combination With GC4419 in Pancreatic Cancer Phase 1/Phase 2
Recruiting NCT04147728 - Stereotactic Radiosurgery Combination With Anlotinib for Limited Brain Metastases With Perilesional Edema in NSCLC Phase 2